Nick Glover

2020

In 2020, Nick Glover earned a total compensation of $4.4M as Former President and Chief Executive Officer at ProNAi Therapeutics, a 132% increase compared to previous year.

Compensation breakdown

Option Awards$3,524,091
Salary$905,148
Other$17,019
Total$4,446,258

Glover received $3.5M in option awards, accounting for 79% of the total pay in 2020.

Glover also received $905.1K in salary and $17K in other compensation.

Rankings

In 2020, Nick Glover's compensation ranked 2,535th out of 13,090 executives tracked by ExecPay. In other words, Glover earned more than 80.6% of executives.

ClassificationRankingPercentile
All
2,535
out of 13,090
81st
Division
Manufacturing
970
out of 5,620
83rd
Major group
Chemicals And Allied Products
352
out of 2,253
84th
Industry group
Drugs
302
out of 1,953
85th
Industry
Pharmaceutical Preparations
220
out of 1,458
85th
Source: SEC filing on April 23, 2021.

Glover's colleagues

We found three more compensation records of executives who worked with Nick Glover at ProNAi Therapeutics in 2020.

2020

Stephen Dilly

ProNAi Therapeutics

Chief Executive Officer

2020

Barbara Klencke

ProNAi Therapeutics

Chief Development Officer

2020

Mark Kowalski

ProNAi Therapeutics

Chief Medical Officer

News

In-depth

You may also like